Products Products
Mutual Funds
Stock Market
NPS Retirement Funds

Company Company
About us
Contact us
1000003271
Paytm
Mutual Funds Stock Market NPS Retirement Funds
About us Contact us

Zydus life

873.40
-7.70 (-0.87%) tick NSE

Buy Sell

Last updated on 20 Jan 2026 11:39 PM

Returns
-3.07%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

88659.28

Earning Per Share

49.98

Dividend Yield

1.25%

P/E Ratio

17.63

P/B Ratio

3.50

Debt to Equity

0.38

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

Zydus Lifesciences Limited, initially known as Cadila Healthcare Limited was incorporated in May, 1995, which changed to Zydus Lifesciences Limited on February 24, 2022. The Company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products. The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. The Company's operation includes pharmaceuticals, which includes human formulations, veterinary formulations and bulk durgs, diagnostics, herbal products, skin care products and OTC products. In the year 1996, the Company made a strategic alliance with Gulin Pharma of China and launched Falcigo in India, which is an anti-malarial segment.

Similar Companies


Login